|

TQB6411 Injection Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Indications

  • Cancer2
  • Advanced Malignant Tumors1
  • Esophageal Cancer1

Other2 trials

A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
Phase 1
Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.